All In Biotech

Free tool

FAERS Monitor: Oxygen, Usp

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205713 or its brand name (Oxygen, Usp, Oxygen). Reports on generic versions are filed under their own applications.

Reports

110

Serious

93

85% of reports

Hospitalization

33

Death reported

14

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use10
  • malaise9
  • drug interaction7
  • accidental exposure to product6
  • psoriasis6
  • completed suicide5
  • dyspnoea5
  • haemodynamic instability5
  • product leakage5
  • ventricular fibrillation5
  • weight decreased5
  • death4
  • dry gangrene4
  • extremity necrosis4
  • injection site reaction4

Reports by year received

View as table
YearReports
20041
20051
20061
20071
20111
20123
20132
20142
20154
20169
201713
201815
20195
20202
20214
20227
202315
202410
20254
202610

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,049 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
dry gangreneSignal41213.3462.23,686
extremity necrosisSignal4439.5167.71,336
product leakageSignal5170.572.4681
haemodynamic instabilitySignal5125.653.3499
ventricular fibrillationSignal586.136.6340
completed suicideSignal511.54.938
accidental exposure to productSignal611.15.146
injection site reactionSignal411.14.227
psoriasisSignal68.84.034
drug interactionSignal78.44.139
malaiseSignal93.92.117
weight decreasedSignal53.41.56
off label useSignal102.21.26
dyspnoea51.70.71
death40.90.30

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.